OACC · Oaktree Acquisition Corp. III Life Sciences · Metrics
$10.69
+0.03 (+0.28%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such potential liquidity shortfalls and mandatory liquidation condition raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$262.05M
Shares
24.58M
Volume · Oct 21
14.64K
Avg daily vol (3M)
58.42K
OACC metrics
47 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$10.69
Market cap
$262.05M
Price action
20 metricsPrice change (1W)
-0.8%
Price change (30D)
-0.7%
Price change (3M)
-0.5%
Price change (6M)
-0.2%
Price change (YTD)
+0.8%
Price change (1Y)
+0.8%
Trailing year
Price change (5Y)
—
52-week high
$10.93
52-week low
$10.50
Change from 52-week high
-2.5%
Change from 52-week low
+1.5%
Annualized volatility
6.5%
Annualized volatility (3M)
—
Beta
0.0
RSI (14D)
42.4
Price vs SMA 50
-0.8%
Price vs SMA 200
+0.3%
Avg volume (3M)
59,543
Relative volume
0.3
Average dollar volume
$640,358
Company
3 metricsSector
Financial Services
Industry
Shell Companies
Shares outstanding
24.58M
Valuation
12 metricsP / E (TTM)
38.8
Trailing earnings · reciprocal yield 2.6%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
2.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$1.20M
Net income (TTM)
$6.75M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
-14.4%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
3.3%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.18M
Latest balance sheet
Cash & equivalents
$1.18M
Total assets
$206.54M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$455,689
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
57
13F filer change QoQ
-1
Institutional ownership
84.1%
Conviction holders (share of 13F filers)
3.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.4%
Holder tenure
5.4
Price vs estimated holder cost
+4.4%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
32 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged